CXCR6 EXPRESSION ENHANCES ACCUMULATION OF ANTI-MESOTHELIN CAR T CELLS AT THE TUMOR SITE AND THEIR THERAPEUTIC EFFICACY IN PANCREATIC CANCER XENOGRAFTS

被引：0
|
作者：
Stoiber, S. [1 ,2 ]
Lesch, S. [1 ,2 ]
Ogonek, J. [1 ,2 ]
Cadilha, B. [1 ,2 ]
Benmebarek, M. [1 ,2 ]
Gottschlich, A. [1 ,2 ]
Metzger, P. [1 ,2 ]
Hoerth, C. [1 ,2 ]
Nottebrock, A. [1 ,2 ]
Endres, S. [1 ,2 ,3 ]
Kobold, S. [1 ,2 ,3 ]
机构：
[1] Klinikum Univ Munchen, German Ctr Lung Res, Center Integrated Prot Sci Munich, Munich, Germany
[2] Klinikum Univ Munchen, German Ctr Lung Res, Div Clin Pharmacol, Dept Med 4, Munich, Germany
[3] German Ctr Translat Canc Res DKTK, Munich, Germany
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020年 / 8卷
关键词：
D O I：
10.1136/jitc-2020-ITOC7.86
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P06.07
引用
收藏
页码：A44 / A44
页数：1
相关论文
共 50 条
  • [1] Efficient growth suppression in pancreatic cancer PDX model by fully human anti-mesothelin CAR-T cells
    Hua Jiang
    Bo Song
    Peng Wang
    Bizhi Shi
    Qixiang Li
    Mingliang Fan
    Shengmeng Di
    Jie Yang
    Zonghai Li
    [J]. Protein & Cell, 2017, 8 (12) - 939
  • [2] Efficient growth suppression in pancreatic cancer PDX model by fully human anti-mesothelin CAR-T cells
    Jiang, Hua
    Song, Bo
    Wang, Peng
    Shi, Bizhi
    Li, Qixiang
    Fan, Mingliang
    Di, Shengmeng
    Yang, Jie
    Li, Zonghai
    [J]. PROTEIN & CELL, 2017, 8 (12) : 926 - 931
  • [3] Tumor resistance to anti-mesothelin CAR-T cells caused by binding to shed mesothelin is overcome by targeting a juxtamembrane epitope
    Liu, X. F.
    Onda, M.
    Schlomer, J.
    Bassel, L.
    Kozlov, S.
    Tai, C. -H.
    Zhou, Q.
    Liu, W.
    Tsao, H. -E.
    Hassan, R.
    Ho, M.
    Pastan, I.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (04)
  • [4] Favorable therapeutic response after anti-Mesothelin antibody–drug conjugate treatment requires high expression of Mesothelin in tumor cells
    Lea Lazzerini
    Korinna Jöhrens
    Jalid Sehouli
    Günter Cichon
    [J]. Archives of Gynecology and Obstetrics, 2020, 302 : 1255 - 1262
  • [5] Favorable therapeutic response after anti-Mesothelin antibody-drug conjugate treatment requires high expression of Mesothelin in tumor cells
    Lazzerini, Lea
    Joehrens, Korinna
    Sehouli, Jalid
    Cichon, Gunter
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2020, 302 (05) : 1255 - 1262
  • [6] Oncolytic Adenovirus Expressing Cytokines Enhances Anti-Tumor Efficacy of Mesothelin-Redirected CAR-T Cells
    Watanabe, Keisuke
    Guedan, Sonia
    Scholler, John
    McGettigan, Shannon
    Luo, Yangpin
    Tahtinen, Siri
    Parviainen, Suvi
    Havunen, Riikka
    Siurala, Mikko
    Hemminki, Akseli
    June, Carl H.
    [J]. BLOOD, 2016, 128 (22)
  • [7] Intra-tumor persistence of activated anti-mesothelin hYP218 CAR T cells is associated with increased efficacy in gastric and colorectal cancers
    Mir, Sameer A.
    Venugopalan, Abhilash
    Zhang, Jingli
    Khanal, Mana Kamana
    Stathopoulou, Chaido
    Sengupta, Manjistha
    Jiang, Qun
    Hassan, Raffit
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [8] Disruption of adenosine 2A receptor improves the anti-tumor function of anti-mesothelin CAR T cells both in vitro and in vivo
    Liu, Guodi
    Zhang, Qian
    Liu, Guoping
    Li, Dehua
    Zhang, Linsong
    Gu, Zhangjie
    Tian, Huixin
    Zhang, Yong
    Tian, Xiaoli
    [J]. EXPERIMENTAL CELL RESEARCH, 2021, 409 (01)
  • [9] Enhancing the Efficacy of CAR T Cells in the Tumor Microenvironment of Pancreatic Cancer
    Henze, Janina
    Tacke, Frank
    Hardt, Olaf
    Alves, Frauke
    Al Rawashdeh, Wa'el
    [J]. CANCERS, 2020, 12 (06)
  • [10] ROLE OF CAR EXPRESSION LEVELS IN THE ANTI-TUMOR EFFICACY OF CAR-T CELLS
    Rodriguez-Marquez, P.
    Calleja-Cervantes, M. E.
    Serrano, G.
    San Martin-Uriz, P.
    Vilas-Zornoza, A.
    Martin-Mallo, A.
    Rodriguez-Diaz, S.
    Martinez-Turrillas, R.
    Jauregui, P.
    Calvino, C.
    Inoges, S.
    Lopez-Diaz, de Cerio A.
    Palacios-Berraquero, M. L.
    Rodriguez-Otero, P.
    Rifon, J.
    Alfonso, A.
    Lasarte, J. J.
    Lozano, T.
    Hernaez, M.
    Rodriguez-Madoz, J. R.
    Prosper, F.
    [J]. HAEMATOLOGICA, 2021, 106 (10) : 58 - 59
12345